• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫抑制糖蛋白与乳腺肿瘤纤维化及侵袭相关。

Immunosuppressive glycoproteins associate with breast tumor fibrosis and aggression.

作者信息

Metcalf Kevin James, Hayward Mary-Kate, Berens Eric, Ironside Alastair J, Stashko Connor, Hwang E Shelley, Weaver Valerie M

机构信息

Department of Surgery, University of California, San Francisco, CA, United States.

Knight Cancer Institute, Oregon Health and Science University, Portland, OR, United States.

出版信息

Matrix Biol Plus. 2022 Mar 9;14:100105. doi: 10.1016/j.mbplus.2022.100105. eCollection 2022 Jun.

DOI:10.1016/j.mbplus.2022.100105
PMID:35392183
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8981759/
Abstract

Tumors feature elevated sialoglycoprotein content. Sialoglycoproteins promote tumor progression and are linked to immune suppression via the sialic acid-Siglec axis. Understanding factors that increase sialoglycoprotein biosynthesis in tumors could identify approaches to improve patient response to immunotherapy. We quantified higher levels of sialoglycoproteins in the fibrotic regions within human breast tumor tissues. Human breast tumor subtypes, which are more fibrotic, similarly featured increased sialoglycoprotein content. Further analysis revealed the breast cancer cells as the primary cell type synthesizing and secreting the tumor tissue sialoglycoproteins and confirmed that the more aggressive, fibrotic breast cancer subtypes expressed the highest levels of sialoglycoprotein biosynthetic genes. The more aggressive breast cancer subtypes also featured greater infiltration of immunosuppressive , , and -pos myeloid cells, indicating that triple-negative breast tumors had higher expression of both immunosuppressive Siglec receptors and their cognate ligands. The findings link sialoglycoprotein biosynthesis and secretion to tumor fibrosis and aggression in human breast tumors. The data suggest targeting of the sialic acid-Siglec axis may comprise an attractive therapeutic target particularly for the more aggressive HER2+ and triple-negative breast cancer subtypes.

摘要

肿瘤的特征是唾液酸糖蛋白含量升高。唾液酸糖蛋白促进肿瘤进展,并通过唾液酸-Siglec轴与免疫抑制相关。了解增加肿瘤中唾液酸糖蛋白生物合成的因素可以确定改善患者对免疫疗法反应的方法。我们定量分析了人类乳腺肿瘤组织纤维化区域中更高水平的唾液酸糖蛋白。纤维化程度更高的人类乳腺肿瘤亚型同样具有增加的唾液酸糖蛋白含量。进一步分析表明,乳腺癌细胞是合成和分泌肿瘤组织唾液酸糖蛋白的主要细胞类型,并证实侵袭性更强、纤维化程度更高的乳腺癌亚型表达唾液酸糖蛋白生物合成基因的水平最高。侵袭性更强的乳腺癌亚型还表现出免疫抑制性、和阳性髓样细胞的浸润增加,表明三阴性乳腺癌肿瘤中免疫抑制性Siglec受体及其同源配体的表达更高。这些发现将唾液酸糖蛋白的生物合成和分泌与人类乳腺肿瘤的纤维化和侵袭性联系起来。数据表明,靶向唾液酸-Siglec轴可能是一个有吸引力的治疗靶点,特别是对于侵袭性更强的HER2+和三阴性乳腺癌亚型。

相似文献

1
Immunosuppressive glycoproteins associate with breast tumor fibrosis and aggression.免疫抑制糖蛋白与乳腺肿瘤纤维化及侵袭相关。
Matrix Biol Plus. 2022 Mar 9;14:100105. doi: 10.1016/j.mbplus.2022.100105. eCollection 2022 Jun.
2
Disruption of the sialic acid/Siglec-9 axis improves antibody-mediated neutrophil cytotoxicity towards tumor cells.破坏唾液酸/ Siglec-9 轴可改善抗体介导的中性粒细胞对肿瘤细胞的细胞毒性。
Front Immunol. 2023 Jun 6;14:1178817. doi: 10.3389/fimmu.2023.1178817. eCollection 2023.
3
Siglec-7 and Siglec-9 expression in primary triple negative and oestrogen receptor positive breast cancer and signalling.Siglec-7和Siglec-9在原发性三阴性和雌激素受体阳性乳腺癌中的表达及信号传导
Clin Transl Immunology. 2024 Sep 6;13(9):e1524. doi: 10.1002/cti2.1524. eCollection 2024 Sep.
4
Targeting myeloid cells for cancer immunotherapy: Siglec-7/9/10/15 and their ligands.针对癌症免疫疗法的髓系细胞:Siglec-7/9/10/15 及其配体。
Trends Cancer. 2024 Mar;10(3):230-241. doi: 10.1016/j.trecan.2023.11.009. Epub 2023 Dec 29.
5
Expression profiling of immune inhibitory Siglecs and their ligands in patients with glioma.免疫抑制性 Siglecs 及其配体在胶质瘤患者中的表达谱分析。
Cancer Immunol Immunother. 2019 Jun;68(6):937-949. doi: 10.1007/s00262-019-02332-w. Epub 2019 Apr 5.
6
Multi-omics analysis of Siglec family genes in cutaneous melanoma.皮肤黑色素瘤中 Siglec 家族基因的多组学分析。
Front Immunol. 2023 May 3;14:1036019. doi: 10.3389/fimmu.2023.1036019. eCollection 2023.
7
Tumor cell-intrinsic and tumor microenvironmental conditions co-determine signaling by the glycoimmune checkpoint receptor Siglec-7.肿瘤细胞内在和肿瘤微环境条件共同决定糖免疫检查点受体 Siglec-7 的信号转导。
Cell Mol Life Sci. 2023 May 30;80(6):169. doi: 10.1007/s00018-023-04816-6.
8
Differential expression of a sialoglycoprotein with an approximate molecular weight of 900,000 on metastatic human colon carcinoma cells growing in culture and in tumor tissues.一种分子量约为900,000的唾液糖蛋白在体外培养的转移性人结肠癌细胞及肿瘤组织中的差异表达。
Cancer Res. 1988 May 1;48(9):2353-60.
9
Sialoglycoproteins of murine RAW117 large cell lymphoma/lymphosarcoma sublines of various metastatic colonization properties.具有不同转移定植特性的小鼠RAW117大细胞淋巴瘤/淋巴肉瘤亚系的唾液糖蛋白
Exp Cell Res. 1986 Aug;165(2):403-16. doi: 10.1016/0014-4827(86)90594-x.
10
The expression of two immunosuppressive SIGLEC family molecules in papillary thyroid cancer and their effect on prognosis.两种免疫抑制性 SIGLEC 家族分子在甲状腺乳头状癌中的表达及其对预后的影响。
Endocrine. 2023 Dec;82(3):590-601. doi: 10.1007/s12020-023-03452-1. Epub 2023 Jul 22.

引用本文的文献

1
Elevated Siglec-7 expression correlates with adverse clinicopathological, immunological, and therapeutic response signatures in breast cancer patients.Siglec-7表达升高与乳腺癌患者不良的临床病理、免疫及治疗反应特征相关。
Front Immunol. 2025 Jun 6;16:1573365. doi: 10.3389/fimmu.2025.1573365. eCollection 2025.
2
Decoding tumor-fibrosis interplay: mechanisms, impact on progression, and innovative therapeutic strategies.解码肿瘤-纤维化相互作用:机制、对进展的影响及创新治疗策略。
Front Pharmacol. 2024 Oct 23;15:1491400. doi: 10.3389/fphar.2024.1491400. eCollection 2024.
3
Siglec-7 and Siglec-9 expression in primary triple negative and oestrogen receptor positive breast cancer and signalling.

本文引用的文献

1
Siglecs-7/9 function as inhibitory immune checkpoints in vivo and can be targeted to enhance therapeutic antitumor immunity.Siglecs-7/9 在体内作为抑制性免疫检查点发挥作用,可作为靶点增强治疗性抗肿瘤免疫。
Proc Natl Acad Sci U S A. 2021 Jun 29;118(26). doi: 10.1073/pnas.2107424118.
2
Integrated analysis of multimodal single-cell data.多模态单细胞数据的综合分析。
Cell. 2021 Jun 24;184(13):3573-3587.e29. doi: 10.1016/j.cell.2021.04.048. Epub 2021 May 31.
3
A single-cell RNA expression atlas of normal, preneoplastic and tumorigenic states in the human breast.
Siglec-7和Siglec-9在原发性三阴性和雌激素受体阳性乳腺癌中的表达及信号传导
Clin Transl Immunology. 2024 Sep 6;13(9):e1524. doi: 10.1002/cti2.1524. eCollection 2024 Sep.
4
Cancer-stromal cell interactions in breast cancer brain metastases induce glycocalyx-mediated resistance to HER2-targeting therapies.乳腺癌脑转移中的肿瘤间质细胞相互作用诱导糖萼介导的对 HER2 靶向治疗的耐药性。
Proc Natl Acad Sci U S A. 2024 May 14;121(20):e2322688121. doi: 10.1073/pnas.2322688121. Epub 2024 May 6.
5
Cancer-specific glycosylation of CD13 impacts its detection and activity in preclinical cancer tissues.CD13的癌症特异性糖基化影响其在临床前癌症组织中的检测及活性。
iScience. 2023 Oct 16;26(11):108219. doi: 10.1016/j.isci.2023.108219. eCollection 2023 Nov 17.
6
The microenvironment dictates glycocalyx construction and immune surveillance.微环境决定糖萼的构建和免疫监视。
Res Sq. 2023 Aug 16:rs.3.rs-3164966. doi: 10.21203/rs.3.rs-3164966/v1.
7
Tamoxifen Modulates the Immune Landscape of the Tumour Microenvironment: The Paired Siglec-5/14 Checkpoint in Anti-Tumour Immunity in an In Vitro Model of Breast Cancer.他莫昔芬调节肿瘤微环境的免疫景观:体外乳腺癌模型中抗肿瘤免疫中的配对 Siglec-5/14 检查点。
Int J Mol Sci. 2023 Mar 14;24(6):5512. doi: 10.3390/ijms24065512.
8
The glycocalyx: Pathobiology and repair.糖萼:病理生物学与修复
Matrix Biol Plus. 2023 Jan 20;17:100128. doi: 10.1016/j.mbplus.2023.100128. eCollection 2023 Feb.
9
Mechanosensitive Steroid Hormone Signaling and Cell Fate.机械敏感性甾体激素信号转导与细胞命运。
Endocrinology. 2022 Aug 1;163(8). doi: 10.1210/endocr/bqac085.
人类乳腺正常、癌前病变和肿瘤发生状态的单细胞 RNA 表达图谱。
EMBO J. 2021 Jun 1;40(11):e107333. doi: 10.15252/embj.2020107333. Epub 2021 May 5.
4
Reciprocal regulation of cellular mechanics and metabolism.细胞力学和代谢的相互调节。
Nat Metab. 2021 Apr;3(4):456-468. doi: 10.1038/s42255-021-00384-w. Epub 2021 Apr 19.
5
Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9.唾液酸在胰腺癌细胞中通过 Siglec 受体 Siglec-7 和 Siglec-9 驱动肿瘤相关巨噬细胞分化。
Nat Commun. 2021 Feb 24;12(1):1270. doi: 10.1038/s41467-021-21550-4.
6
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7.全基因组 CRISPR 筛选揭示了糖结合免疫检查点受体 Siglec-7 的特定配体。
Proc Natl Acad Sci U S A. 2021 Feb 2;118(5). doi: 10.1073/pnas.2015024118.
7
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans.糖生物学的临床影响:靶向选择素、Siglecs 和哺乳动物聚糖。
Nat Rev Drug Discov. 2021 Mar;20(3):217-243. doi: 10.1038/s41573-020-00093-1. Epub 2021 Jan 18.
8
Tumour-associated macrophages drive stromal cell-dependent collagen crosslinking and stiffening to promote breast cancer aggression.肿瘤相关巨噬细胞驱动基质细胞依赖性胶原交联和变硬,促进乳腺癌侵袭。
Nat Mater. 2021 Apr;20(4):548-559. doi: 10.1038/s41563-020-00849-5. Epub 2020 Nov 30.
9
An Acquired and Endogenous Glycocalyx Forms a Bidirectional "Don't Eat" and "Don't Eat Me" Barrier to Phagocytosis.获得性和内源性糖萼形成双向“不要吞噬”和“不要被吞噬”的吞噬屏障。
Curr Biol. 2021 Jan 11;31(1):77-89.e5. doi: 10.1016/j.cub.2020.09.082. Epub 2020 Oct 22.
10
Concepts of extracellular matrix remodelling in tumour progression and metastasis.肿瘤进展和转移中外细胞基质重塑的概念。
Nat Commun. 2020 Oct 9;11(1):5120. doi: 10.1038/s41467-020-18794-x.